12:00 AM
 | 
Jan 20, 2014
 |  BC Week In Review  |  Clinical News  |  Clinical Status

NOxCureCF: Phase II started

Advanced Inhalation Therapies began an open-label, Israeli Phase II trial to evaluate NOxCureCF in CF patients ages...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >